Literature DB >> 25896753

Infectious complications of pancreatic islet transplantation: clinical experience and unanswered questions.

Stephanie M Pouch1.   

Abstract

Pancreatic islet transplantation is an evolving treatment modality for type I diabetes mellitus. While the field has advanced significantly over the course of the past three decades, our understanding of the infectious complications of pancreatic islet transplantation remains quite limited. This review aims to describe the current literature relating to infectious complications of pancreatic islet transplantation, including the role of microbiologically contaminated islet preparations in disease pathogenesis, our current understanding of the epidemiology and outcomes of cytomegalovirus and other infectious complications of pancreatic islet transplantation, and infectious concerns related to the use of porcine pancreatic islet cell xenografts. This review also highlights unanswered clinical questions and suggests areas of future research to mitigate infectious complications in recipients of islet transplantation.

Entities:  

Year:  2015        PMID: 25896753     DOI: 10.1007/s11908-015-0482-9

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  45 in total

1.  Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation.

Authors:  Muhammad M Hafiz; Raquel N Faradji; Tatiana Froud; Antonello Pileggi; David A Baidal; Pablo Cure; Gaston Ponte; Raffaella Poggioli; Agustin Cornejo; Shari Messinger; Camillo Ricordi; Rodolfo Alejandro
Journal:  Transplantation       Date:  2005-12-27       Impact factor: 4.939

2.  Regulatory aspects of pig-to-human islet transplantation.

Authors:  Henk-Jan Schuurman
Journal:  Xenotransplantation       Date:  2008 Mar-Apr       Impact factor: 3.907

3.  No evidence of infection with porcine endogenous retrovirus in recipients of encapsulated porcine islet xenografts.

Authors:  R B Elliott; L Escobar; O Garkavenko; M C Croxson; B A Schroeder; M McGregor; G Ferguson; N Beckman; S Ferguson
Journal:  Cell Transplant       Date:  2000 Nov-Dec       Impact factor: 4.064

Review 4.  Microbial safety in xenotransplantation.

Authors:  Nicolas J Mueller; Yasuhiro Takeuchi; Giada Mattiuzzo; Linda Scobie
Journal:  Curr Opin Organ Transplant       Date:  2011-04       Impact factor: 2.640

5.  Late cytomegalovirus transmission and impact of T-depletion in clinical islet transplantation.

Authors:  B L Gala-Lopez; P A Senior; A Koh; S M Kashkoush; T Kawahara; T Kin; A Humar; A M J Shapiro
Journal:  Am J Transplant       Date:  2011-09-11       Impact factor: 8.086

6.  Community-acquired MRSA and pig-farming.

Authors:  Xander W Huijsdens; Beatrix J van Dijke; Emile Spalburg; Marga G van Santen-Verheuvel; Max E O C Heck; Gerlinde N Pluister; Andreas Voss; Wim J B Wannet; Albert J de Neeling
Journal:  Ann Clin Microbiol Antimicrob       Date:  2006-11-10       Impact factor: 3.944

7.  Case report: diabetic myonecrosis of the neck complicated by infection in an islet transplanted patient.

Authors:  Payam Salehi; Margaret A Stull; Joan Martellotto; Antonio Gangemi; Betul Hatipoglu; Enrico Benedetti; Josè Oberholzer
Journal:  J Diabetes Complications       Date:  2008-03-21       Impact factor: 2.852

8.  The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 5: Strategies to prevent transmission of porcine endogenous retroviruses.

Authors:  Joachim Denner; Henk-Jan Schuurman; Clive Patience
Journal:  Xenotransplantation       Date:  2009 Jul-Aug       Impact factor: 3.907

9.  Total or near total pancreatectomy and islet autotransplantation for treatment of chronic pancreatitis.

Authors:  J S Najarian; D E Sutherland; D Baumgartner; B Burke; J J Rynasiewicz; A J Matas; F C Goetz
Journal:  Ann Surg       Date:  1980       Impact factor: 12.969

10.  Staphylococcus aureus ST398, New York City and Dominican Republic.

Authors:  Meera Bhat; Caroline Dumortier; Barbara S Taylor; Maureen Miller; Glenny Vasquez; Jose Yunen; Karen Brudney; Jacqueline Sánchez-E; Carlos Rodriguez-Taveras; Rita Rojas; Patricia Leon; Franklin D Lowy
Journal:  Emerg Infect Dis       Date:  2009-02       Impact factor: 6.883

View more
  2 in total

Review 1.  Biomaterials as carrier, barrier and reactor for cell-based regenerative medicine.

Authors:  Chunxiao Qi; Xiaojun Yan; Chenyu Huang; Alexander Melerzanov; Yanan Du
Journal:  Protein Cell       Date:  2015-06-19       Impact factor: 14.870

2.  Prophylactically Decontaminating Human Islet Product for Safe Clinical Application: Effective and Potent Method.

Authors:  Meirigeng Qi; Keiko Omori; Yoko Mullen; Brian McFadden; Luis Valiente; Jemily Juan; Shiela Bilbao; Bernard R Tegtmeier; Donald Dafoe; Fouad Kandeel; Ismail H Al-Abdullah
Journal:  Transplant Direct       Date:  2016-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.